ASC22 (Envafolimab) is a subcutaneously administered single-domain antibody against PD-L1 and has the potential to restore virus-specific immune responses in patients with chronic viral infection
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year
Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer
The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.
The plant is scheduled to come on stream in September 2024
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years
Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023
Subscribe To Our Newsletter & Stay Updated
